Westover Capital Advisors’s Hologic HOLX Stock Holding History

Westover Capital Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,700	Closed	-$204K	–	247
2026 Q1	$204K	Buy	+2,700	New	+$203K	0.04%	232
2021 Q4	–	Sell	-7,347	Closed	-$542K	–	184
2021 Q3	$542K	Sell	7,347 -28	-0.4%	-$2.1K	0.17%	97
2021 Q2	$492K	Buy	7,375 +793	+12%	+$53K	0.16%	103
2021 Q1	$490K	Buy	+6,582	New	+$500K	0.17%	103
2014 Q3	–	Sell	-8,988	Closed	-$228K	–	92
2014 Q2	$228K	Buy	+8,988	New	+$210K	0.19%	82

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Westover Capital Advisors's HOLX Position: Q2 2026 in Review

Westover Capital Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,700 shares — an estimated $204K sold.

Westover Capital Advisors first reported a position in HOLX in Q2 2014 and held it in 5 quarters. The position peaked at $542K in Q3 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Westover Capital Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Westover Capital Advisors sold 2,700 Hologic shares in Q2 2026, an estimated $204K.
Westover Capital Advisors first reported a position in Hologic in Q2 2014 and held it in 5 quarters.
Westover Capital Advisors's Hologic position peaked at $542K in Q3 2021.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Westover Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.